...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of alternative and complementary medicine: research on paradigm, practice, and policy >Treatment of Goiter with Traditional Chinese Medicine Regimen Xing Qi Hua Ying Tang: A Clinical Study on 72 Patients with Multinodular and Diffuse Goiter
【24h】

Treatment of Goiter with Traditional Chinese Medicine Regimen Xing Qi Hua Ying Tang: A Clinical Study on 72 Patients with Multinodular and Diffuse Goiter

机译：用中医枸杞治疗邢琪华莹唐：72例多内透明甲状腺肿患者的临床研究

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: The present work aimed to further explore the therapeutic potential of Xing Qi Hua Ying Tang (XQHYT) by conducting a systemic clinical study in patients with goiter. Design: Seventy-two patients with either multinodular or diffuse goiter were enrolled and randomly assigned into treatment group receiving XQHYT (n=36) and control group receiving Hai Zao Yu Hu Tang (n=36). Location: Traditional Chinese Medicine Hospital of Shanxi. Subjects: Patients were diagnosed multinodular goiter or diffuse goiter resulting from Qi stagnation. Intervention: All patients took the extract twice a day (100mL each time) for two courses of treatment, of which a single course lasted for 3 months. Before the treatment was commenced and after the completion of the treatment, general body checks, thyroid function test, and goiter size examination were performed. Outcome measures: Scoring of the clinical symptoms using Chinese medicine symptomatology was also done. Results: The symptom score of the treatment group was significantly lower than that of the control group (treatment group, 8.262.62; control group, 10.02 +/- 2.62; p0.05). Substantial reduction in goiter size was seen in 82.3% of XQHYT-treated patients, whereas in the control group only 67.7% of patients exhibited constricted goiter. When assessed by both the Chinese medicine criteria and goiter size, the overall effective rate of the treatment group was 91.2%, whereas that of the control group was only 67.7%. The difference was statistically significant (p0.05). XQHYT did not affect the normal functions of liver, kidney, and heart. For both groups of patients, their levels of thyroid-stimulating hormone, free T4 and free T3 were normal before the treatment, and were not affected by the treatment. Conclusion: XQHYT was shown to be a promising therapeutic regimen for the treatment of goiter. The herbal regimen ameliorated clinical symptoms of patients that were accompanied with reduction in the size of goiter.
机译：目的：目前的工作旨在通过对甲状腺肿患者进行全身临床研究，进一步探讨兴琦华莹汤（XQHYT）的治疗潜力。设计：七十二名患有多环或弥漫孔剂的患者被纳入并随机分配到接受XQHYT（n = 36）和对照组接受海枣的对照组（n = 36）。地点：山西中医院。受试者：患者被诊断为QI停滞的多型甲状腺肿或漫射核头。干预：所有患者每天服用两次摘要（每次100ml）两种治疗疗程，其中单个课程持续3个月。在进行治疗之前和完成治疗后，一般身体检查，甲状腺功能测试和甲状腺尺寸检查进行。结果措施：使用中医症状的临床症状评分也完成了。结果：治疗组的症状得分明显低于对照组（治疗组，8.262.62;对照组，10.02 +/- 2.62; P <0.05）。在82.3％的XQHYT治疗的患者中，甲状腺肿大小的大大减少，而在对照组中，只有67.7％的患者表现出收缩甲状腺肿。当通过中药标准和甲状腺系统尺寸进行评估时，治疗组的总体有效率为91.2％，而对照组仅为67.7％。差异是统计学上显着的（P <0.05）。 XQHYT不影响肝，肾和心脏的正常功能。对于两组患者，它们在治疗前的甲状腺刺激激素，免费T4和游离T3的水平，并且不受治疗的影响。结论：XQHYT被证明是治疗甲状腺肿的有希望的治疗方案。草药方案改善了伴随着减少甲状腺系的患者的临床症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号